Düsseldorf, Germany

Matthias Schneider

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Protagen Ag, Universität Zu Koln. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Schneider. Retrieved from https://idiyas.com/inventor/matthias-schneider-6342k2qt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Matthias Schneider - Innovator in Diagnostic Technologies

Introduction

Matthias Schneider is an inventor based in Dusseldorf, Germany. He is known for his contributions to the field of diagnostic technologies, particularly in relation to systemic lupus erythematosus. Although he currently holds no granted patents, his innovative ideas have the potential to impact medical diagnostics significantly.

Latest Patent Applications

One of Matthias Schneider's notable patent applications is titled "MARKER SEQUENCES FOR SYSTEMIC LUPUS ERYTHEMATOSUS AND THE USE THEREOF." This invention relates to novel marker sequences for systemic lupus erythematosus and their application in diagnosis. It also includes a method for screening potential active ingredients for systemic lupus erythematosus diseases using these marker sequences. Furthermore, the invention encompasses a diagnostic device that incorporates such marker sequences, particularly focusing on a protein biochip and its applications.

Conclusion

Matthias Schneider's work in developing diagnostic technologies for systemic lupus erythematosus showcases his innovative spirit and dedication to advancing medical science. His contributions, although not yet patented, hold promise for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…